Skip to main content
Industrial Research And Consultancy Centre
Patent
Green Synthesis of Pegylated-Tungsten Disulfide Quantum Dots
Abstract

This patent presents a method for synthesizing water-soluble WS2 quantum dots, addressing the challenge of poor solubility of WS2 in aqueous environments. By dispersing WS2 powder in water with PEG followed by sonication and hydrothermal heating, the invention achieves WS2 quantum dots with enhanced dispersibility and biocompatibility, crucial for biomedical applications.

Figure (1) (a-c) Transmission Electron microscope images (d) High resolution image (e) Diffraction Pattern and (f) The energy dispersive X-ray spectroscopy of PEG_WS2Quantum Dots

Problem Statement

Current methods for synthesizing WS2 quantum dots (QDs) using organic solvents result in poor solubility, limiting their biological applications.

Uniqueness of the Solution
  • PEG as a Surfactant: PEG plays a dual role by dispersing WS2 and preventing aggregation during synthesis. 
  • Sonication and Hydrothermal Heating: These processes ensure uniform size and morphology of WS2 quantum dots, critical for consistent optical and biomedical performance. 
  • Water Solubility: Achieved through careful control of PEG to WS2 ratio, ensuring stable aqueous dispersion suitable for biomedical applications. 

    Advantages of the technology: 

  • Biocompatibility: WS2 quantum dots synthesized using this method exhibit low cytotoxicity and good cell permeability, crucial for biomedical applications. 
  • Scalability: Green synthesis approach allows for large-scale production of uniform WS2 quantum dots suitable for industrial applications. 
  • Optical Properties: Enhanced fluorescence and photoluminescence properties make WS2 quantum dots ideal for optical and sensing applications.
Prototype Details
  • Uniformity: WS2 quantum dots with a diameter of approximately 3.10±0.72 nm, characterized by TEM and high-resolution imaging techniques. 
  • Crystallinity: Structural analysis confirming crystalline nature and stability of quantum dots in aqueous environments. 
  • Performance: Optical and fluorescence properties suitable for various biomedical and optoelectronic applications, validated through experimental setups and characterization techniques.
Current Status of Technology

The technology is patented.

Technology readiness level

2

Societal Impact

Enables safer and more effective biomedical applications of WS2 quantum dots due to improved solubility and biocompatibility.

Applications or Domain
  • Biomedical Imaging: WS2 quantum dots can serve as fluorescent probes for cellular and tissue imaging. 
  • Therapeutics: Potential in photothermal therapy and drug delivery due to their biocompatibility and photoresponsive properties. 
  • Sensor Technology: Utilization in high-sensitivity sensors for environmental monitoring and medical diagnostics.

Geography of IP

Type of IP

Application Number

202021037515

Filing Date
Grant Number

432989

Grant Date
Assignee(s)
Indian Institute of Technology Bombay
**This IP is owned by IIT Bombay**